Related Experiment Video

Updated: May 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Respiratory review of 2012: pneumonia

Young-Soon Yoon1

  • 1Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.

Tuberculosis and Respiratory Diseases
|November 21, 2012
PubMed

Insights

Recent advances in pneumonia care include new classifications, biomarkers, and treatments for various types like community-acquired pneumonia. This summary covers recent developments in diagnosis, prognosis, and prevention, including the 2009 H1N1 pandemic.

Area of Science:

  • Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Pneumonia causes significant illness and death despite medical progress.
  • Misdiagnosis and mistreatment of pneumonia have been common issues.
  • Pneumonia classification now includes community-acquired, health care-associated, hospital-acquired, and ventilator-associated types, each with distinct characteristics.

Purpose of the Study:

  • To review recent advancements in pneumonia diagnosis and treatment.
  • To highlight new concepts in pneumonia biomarkers, prognosis, and prevention.
  • To discuss the impact of the 2009 pandemic H1N1 on pneumonia research.

Main Methods:

  • Literature review of studies published within the past two years.
  • Analysis of recent classifications of pneumonia.
  • Examination of emerging trends in pneumonia management.

Main Results:

  • New diagnostic tools and biomarkers are improving pneumonia detection.
  • Treatment strategies are evolving for different pneumonia classifications.
  • The 2009 pandemic H1N1 significantly influenced recent research directions.

Conclusions:

  • Ongoing research is crucial for improving pneumonia outcomes.
  • Understanding distinct pneumonia types aids in targeted treatment.
  • Recent advancements offer hope for reducing pneumonia's morbidity and mortality.
Keywords:
DiagnosisPneumoniaPrevention and ControlPrognosisTherapeutics

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.